Cancer BiologyJCI InsightPeer-reviewed
Global immune fingerprinting in glioblastoma reveals immune-suppression signatures associated with prognosis
T. J. Alban, A. G. Alvarado, M. D. Sorensen…·J. D. Lathia
The paper identifies immune-suppression signatures in glioblastoma (GBM) patients, showing elevated myeloid-derived suppressor cells (MDSCs) linked to poor prognosis and reduced survival.
DOI 10.1172/jci.insight.122264